sellWeak cluster of 3
Leslie D. Funtleyder sold $6,381 of APLT
See Remarks at Applied Therapeutics, Inc.. 14,502 shares at an average of $0.44, traded Mar 4, 2025, filed Mar 6, 2025.
Warning score
30Value
$6,381
14,502 shares
Holdings after
390,459
-4% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- 0Trade size$6k at market
- 0Share of holdings soldSold 3.6% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-25-035041, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 4, 2025 | SOpen-market sale Common Stock | -14,502 | $0.44 | $6,381 | 390,459 | Mar 6, 2025 |
Related signals
Other insiders at Applied Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | APLTsell Applied Therapeutics, Inc. | Stacy J. Kanter director | $4,816 43,000 shares | -40% | |
| 30Weak | Applied Therapeutics, Inc. | Constantine Chinoporos See Remarks | $197 447 shares | -0% | |
| 30Weak | Applied Therapeutics, Inc. | Riccardo Perfetti Chief Medical Officer | $4,561 10,366 shares | -1% | |
| 30Weak | Applied Therapeutics, Inc. | Constantine Chinoporos See Remarks | $17k 28,117 shares | -9% | |
| 37Weak | Applied Therapeutics, Inc. | Riccardo Perfetti Chief Medical Officer | $53k 86,078 shares | -9% | |
| 30Weak | Applied Therapeutics, Inc. | Leslie D. Funtleyder See Remarks | $14k 22,950 shares | -5% | |
| 48Moderate | Applied Therapeutics, Inc. | Leslie D. Funtleyder Chief Financial Officer | $155k 28,727 shares | -9% | |
| 43Moderate | Applied Therapeutics, Inc. | Adam Hansard Chief Commercial Officer | $263k 48,871 shares | -6% | |
| 49Moderate | Applied Therapeutics, Inc. | Riccardo Perfetti Chief Medical Officer | $597k 110,804 shares | -10% | |
| 65Notable | Applied Therapeutics, Inc. | Shoshana Shendelman President and CEO | $1.7M 318,573 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.